Andrew Booth, Chief Financial Officer at AbCellera Biologics Inc. (ABCL), sold 1,200,000 shares at $25.50 ($30.6M) on 2021-06-09, disclosed to the SEC on 2021-06-10.
Open-market sale of $30.6M ABCL by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ABCL | BUY | 2023-05-26 | $99K | — | Filing → |
| ABCL | BUY | 2022-05-16 | $492K | — | Filing → |
| ABCL | BUY | 2021-11-15 | $993K | — | Filing → |